UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 15

 

CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION

UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934

OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934.

 

Commission File Number 001-35112

 

Aevi Genomic Medicine, LLC

(Exact name of registrant as specified in its charter)

 

435 Devon Park Drive, Suite 715

Wayne, Pennsylvania 19087

 

(610) 254-4201

(Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices)

 

Common Stock, $0.0001 par value per share

(Title of each class of securities covered by this Form)

 

None

(Title of all other classes of securities for which a duty to file reports under Section 13(a) or 15(d) remains)

 

Please place an X in the box(es) to designate the appropriate rule provision(s) relied upon to terminate or suspend the duty to file reports:

 

    Rule 12g-4(a)(1)   x
    Rule 12g-4(a)(2)   ¨
    Rule 12h-3(b)(1)(i)   x
    Rule 12h-3(b)(1)(ii)   ¨
    Rule 15d-6   ¨
    Rule 15d-22(b)   ¨

 

Approximate number of holders of record as of the certification or notice date: One

 

Pursuant to the requirements of the Securities Exchange Act of 1934, Aevi Genomic Medicine, LLC has caused this certification/notice to be signed on its behalf by the undersigned duly authorized person.

 

Date: February 14, 2020   Aevi Genomic Medicine, LLC
     
    By:  

/s/ Michael F. Cola

    Name:     Michael F. Cola
    Title:   Vice President

 

 

 

Aevi Genomic Medicine (NASDAQ:GNMX)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Aevi Genomic Medicine Charts.
Aevi Genomic Medicine (NASDAQ:GNMX)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Aevi Genomic Medicine Charts.